Possible Side Effects Some patients notice mild nausea, bloating, or constipation during the first few weeks
Continue working with your provider on a regular basis while taking any medication, including GLPs
While GLP-1 receptor agonists are not specifically indicated for treating leptin resistance, they produce weight loss benefits via mechanisms that appear to work independently of leptin signalling pathways
Genetics can influence obesity risk, appetite regulation, and metabolic health
Semaglutide selectively activates the GLP-1 receptor, producing: Glucose-dependent insulin secretion : Reduces hypoglycemia risk compared to non-incretin agents Glucagon suppression : Reduces hepatic glucose output in the hyperglycemic state Gastric emptying delay : Contributes to postprandial glucose control and satiety Central appetite regulation : Acts on GLP-1 receptors in the hypothalamus and brainstem to reduce hunger and alter food preferences The simplicity of semaglutide's single-receptor mechanism is both a limitation (no energy expenditure enhancement from glucagon) and a strength (thoroughly understood pharmacology, predictable effects, extensive safety characterization)
How to Draw Your Dose After Reconstitution Reconstitution gets the solution into the vial